Is Sodium Acetate Injection in shortage?
Yes. Sodium Acetate Injection is on FDA’s drug shortage list (limited availability), last updated Oct 1, 2026.
Why it’s in shortage
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)
Maker contact: 833-251-8463
- Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)
Maker contact: 833-251-8463
- Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)
Maker contact: 833-251-8463
- Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)
Estimated recovery: TBD
Maker contact: 833-251-8463
- Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)
Maker contact: 844-646-4398
- Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)
Maker contact: 844-646-4398
- Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)
Maker contact: 844-646-4398
- Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)
Maker contact: 844-646-4398
- Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)
Maker contact: 844-646-4398
- Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)
Additional lots will be available. Product will be made available as it is released.
Maker contact: 800-631-2174
- Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)
Additional lots will be available. Product will be made available as it is released.
Maker contact: 800-631-2174
- Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)
Maker contact: 732-554-1037
- Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)
Maker contact: 732-554-1037
- Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)
Next Delivery and Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Sodium Acetate Injection:
- Mckesson Medical-Surgical Inc. Corporate Office recalls BSS Sterile Irrigating Solution (balanced salt solution), 500 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC
- Mckesson Medical-Surgical Inc. Corporate Office recalls BSS Sterile Irrigating Solution (balanced salt solution), 15 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC
- Fresenius Kabi USA, LLC recalls Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC
- Fresenius Kabi USA, LLC recalls KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free],
- Hospira Inc. recalls Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST,
Sodium Acetate Injection shortage questions
Is Sodium Acetate Injection in shortage?
Yes. Sodium Acetate Injection is on FDA’s drug shortage list (limited availability), last updated Oct 1, 2026.
Why is there a Sodium Acetate Injection shortage?
FDA records the reason as: Other.
What should I do if I can’t get Sodium Acetate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.